Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Protexin Balance is a multi-strain probiotic dietary supplement that also contains a prebiotic. It is composed of seven strains of beneficial bacteria: *Lactobacillus casei*, *Lactobacillus rhamnosus*, *Streptococcus thermophilus*, *Lactobacillus acidophilus*, *Bifidobacterium breve*, *Bifidobacterium longum*, and *Lactobacillus bulgaricus*, along with fructooligosaccharide (FOS). Manufactured by Protexin (part of ADM), the product is intended to support digestive and immune system health by restoring and maintaining a healthy balance of intestinal flora. [1, 2, 3] Clinical studies and general use suggest its potential benefits for conditions such as irritable bowel syndrome (IBS), nonalcoholic fatty liver disease (NAFLD), diarrhea, and digestive upset following antibiotic use or stress. [1, 2, 3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Protexin Balance.